Validating Patient Prioritization in the 2018 Revised UNOS Heart Allocation System: A Single Center ExperienceJOURNAL OF HEART AND LUNG TRANSPLANTATIONIF62019-04-010PREAI
Effects of Induction on the Risk of Post-Transplant De Novo DSAJOURNAL OF HEART AND LUNG TRANSPLANTATIONIF62019-04-010PREAI
Risk of dnDSA with Various MCS Devices as Bridge-to-TransplantJOURNAL OF HEART AND LUNG TRANSPLANTATIONIF62019-04-010PREAI
Mortality in status 2 patients listed for heart transplantation in the United States: Will understanding cause of death help justify implantation of left ventricular assist devices into less sick patients?INTERNATIONAL JOURNAL OF CARDIOLOGYIF3.22019-02-012PREAI
Racial differences in the development of de-novo donor-specific antibodies and treated antibody-mediated rejection after heart transplantationJOURNAL OF HEART AND LUNG TRANSPLANTATIONIF62018-04-0130PREAI
Preemptive vs. Upfront CMV Prophylaxis Strategies and the Risk of Treated CMV in Intermediate Risk Heart Transplant RecipientsJOURNAL OF HEART AND LUNG TRANSPLANTATIONIF62018-04-010PREAI
Preemptive vs. Upfront CMV Prophylaxis Strategies and Risk of Non-CMV Herpesvirus Infections in Intermediate Risk Heart Transplant RecipientsJOURNAL OF HEART AND LUNG TRANSPLANTATIONIF62018-04-010PREAI
Risk of Post-Transplant De Novo Donor Specific Antibodies in Patients Receiving Transfusions PerioperativelyJOURNAL OF HEART AND LUNG TRANSPLANTATIONIF62018-04-010PREAI
Patients Bridged to Transplant with Durable LVAD Support Have a Higher Risk of Post-Transplant De Novo Donor Specific AntibodiesJOURNAL OF HEART AND LUNG TRANSPLANTATIONIF62018-04-010PREAI
Continuation of Beta Blocker Therapy Reduces Hospitalizations in Patients Treated with Milrinone as a Bridge to TransplantJOURNAL OF CARDIAC FAILUREIF8.22017-08-010OAAI
Utility of Neurohormonal Blockade in Patients Receiving Milrinone as Bridge to TransplantJOURNAL OF CARDIAC FAILUREIF8.22017-08-010PREAI
Do the Reasons That Patients are Ineligible for Advanced Heart Failure Therapies Vary According to Insurance TypeJOURNAL OF CARDIAC FAILUREIF8.22016-08-011OAAI
Warfarin, Rifampin, and LVADs-OH MY: Effect of Rifampin on INR and Time in the Therapeutic Range in Patients with a Left Ventricular Assist DeviceJOURNAL OF HEART AND LUNG TRANSPLANTATIONIF62016-04-010OAAI
Elevated Levels of 11-dehydrothromboxane B2 in Urine Is Associated with an Increased Risk of Bleeding in Patients Supported with a Continuous Flow-Left Ventricular Assist DeviceJOURNAL OF HEART AND LUNG TRANSPLANTATIONIF62016-04-010PREAI
De Novo DQ Donor-Specific Antibodies Are Associated with Worse Outcomes Compared to Non-DQ DSA Following Heart TransplantationJOURNAL OF HEART AND LUNG TRANSPLANTATIONIF62016-04-011OAAI
Gender differences in the risk of stroke during support with continuous-flow left ventricular assist deviceJOURNAL OF HEART AND LUNG TRANSPLANTATIONIF62015-12-0143PREAI
Mortality in Status 2 Patients Listed for Heart Transplantation in the United States: Will Understanding Mode of Death Help Justify Implantation of Left Ventricular Assist Devices Into Less Sick Patients?JOURNAL OF CARDIAC FAILUREIF8.22015-08-010PREAI
Improved Outcomes for Women on the Heart Transplant Wait List in the Modern EraJOURNAL OF CARDIAC FAILUREIF8.22015-07-0123PREAI
Race and ethnic differences in the epidemiology and risk factors for graft failure after heart transplantationJOURNAL OF HEART AND LUNG TRANSPLANTATIONIF62015-06-0130PREAI